For Cameroonian pharmaceutical companies to export finished formulations to India, they must navigate the CDSCO registration process. This involves appointing an authorized Indian agent to represent them in India. The registration requires submission of Form 40, along with a comprehensive dossier that includes:
- Plant Master File: Detailed information about the manufacturing facility, including layout, equipment, and quality control measures.
- Site Master File: Documentation of the manufacturing process, quality assurance protocols, and compliance with Good Manufacturing Practices (GMP).
- Free Sale Certificate: Evidence that the product is freely sold in the country of origin.
- Certificate of Pharmaceutical Product (COPP): Confirmation that the product is approved for sale in the exporting country.
The timeline for approval can vary, but it typically ranges from several months to over a year, depending on the completeness of the application and the need for additional information or inspections.